FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385216123> ?p ?o ?g. }

• W4385216123 abstract "Studies indicate antenatal opioid use is associated with birth size deficits, as evidenced by reductions in birth weight and head circumference. However, there remains a limited understanding of how early this growth restriction occurs, and what specific parameters are affected. This novel study evaluated global and specific growth deficits associated with prenatal opioid exposure between 18-22 weeks' gestation as assessed during anatomy ultrasounds.Pregnant women who completed an anatomy ultrasound were identified via electronic medical records from a large academic obstetric practice. The study group used opioids, with tobacco and/or marijuana use permitted (n = 41). The control group could have used tobacco and/or marijuana, but not opioids (n = 308). Neither group had alcohol or other drug exposure. Records were reviewed for medical history and ultrasound size parameters, coded as percentiles for gestational age.Demographics and medical histories were compared with several significant differences noted. After controlling for these differences, significant (p < 0.05) growth deficits were identified in opioid-exposed fetuses. Specifically, reductions >10 percentile points were observed in head circumference, biparietal diameter, and humerus length for opioid-exposed fetuses compared to controls. Additionally, intrauterine growth restriction (IUGR) was diagnosed five times more often. Femur length was significantly reduced in opioid-exposed fetuses prior to adjustment for confounding (p = .016), but this reduction was not significant (p = .072) after controlling for background differences. Estimated fetal weight (p = .274) and abdominal circumference (p = .633) were not significantly different between exposure groups.Fetal opioid exposure predicted various bone growth deficits during routine anatomy ultrasound, indicating the effects of opioid exposure on size deficits may be evident as early as 18-22 weeks' gestation. These findings may also suggest that in utero opioid exposure negatively impacts bone growth specifically rather than weight or fat/muscle mass. Additional studies with larger sample sizes may also reveal significantly reduced femur length, further supporting a negative impact on bone growth. Future studies evaluating bone health and immune function in children after antenatal opioid exposure may help clarify this specific effect of opioids on bone development." @default.
• W4385216123 created "2023-07-25" @default.
• W4385216123 creator A5004638947 @default.
• W4385216123 creator A5010724267 @default.
• W4385216123 creator A5010740005 @default.
• W4385216123 creator A5013940551 @default.
• W4385216123 creator A5016977405 @default.
• W4385216123 creator A5038468267 @default.
• W4385216123 creator A5046417392 @default.
• W4385216123 creator A5089445658 @default.
• W4385216123 creator A5091115906 @default.
• W4385216123 date "2023-07-24" @default.
• W4385216123 modified "2023-09-26" @default.
• W4385216123 title "<i>In utero</i> effects of opioids on fetal growth" @default.
• W4385216123 cites W1969447048 @default.
• W4385216123 cites W1980039229 @default.
• W4385216123 cites W2000263179 @default.
• W4385216123 cites W2009000630 @default.
• W4385216123 cites W2009268789 @default.
• W4385216123 cites W2053504394 @default.
• W4385216123 cites W2077969372 @default.
• W4385216123 cites W2094536436 @default.
• W4385216123 cites W2124202867 @default.
• W4385216123 cites W2295442039 @default.
• W4385216123 cites W3043018615 @default.
• W4385216123 cites W3086254383 @default.
• W4385216123 cites W3120157478 @default.
• W4385216123 cites W3160627571 @default.
• W4385216123 cites W3162957165 @default.
• W4385216123 cites W4200272123 @default.
• W4385216123 cites W4210536753 @default.
• W4385216123 cites W4221133256 @default.
• W4385216123 cites W4223541021 @default.
• W4385216123 cites W4286565894 @default.
• W4385216123 doi "https://doi.org/10.1080/14767058.2023.2238239" @default.
• W4385216123 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37487761" @default.
• W4385216123 hasPublicationYear "2023" @default.
• W4385216123 type Work @default.
• W4385216123 citedByCount "0" @default.
• W4385216123 crossrefType "journal-article" @default.
• W4385216123 hasAuthorship W4385216123A5004638947 @default.
• W4385216123 hasAuthorship W4385216123A5010724267 @default.
• W4385216123 hasAuthorship W4385216123A5010740005 @default.
• W4385216123 hasAuthorship W4385216123A5013940551 @default.
• W4385216123 hasAuthorship W4385216123A5016977405 @default.
• W4385216123 hasAuthorship W4385216123A5038468267 @default.
• W4385216123 hasAuthorship W4385216123A5046417392 @default.
• W4385216123 hasAuthorship W4385216123A5089445658 @default.
• W4385216123 hasAuthorship W4385216123A5091115906 @default.
• W4385216123 hasBestOaLocation W43852161231 @default.
• W4385216123 hasConcept C105795698 @default.
• W4385216123 hasConcept C122048520 @default.
• W4385216123 hasConcept C126322002 @default.
• W4385216123 hasConcept C126838900 @default.
• W4385216123 hasConcept C131872663 @default.
• W4385216123 hasConcept C143753070 @default.
• W4385216123 hasConcept C170493617 @default.
• W4385216123 hasConcept C172680121 @default.
• W4385216123 hasConcept C201614185 @default.
• W4385216123 hasConcept C2777652975 @default.
• W4385216123 hasConcept C2778194526 @default.
• W4385216123 hasConcept C2778376644 @default.
• W4385216123 hasConcept C2778780700 @default.
• W4385216123 hasConcept C2779234561 @default.
• W4385216123 hasConcept C2781063702 @default.
• W4385216123 hasConcept C33923547 @default.
• W4385216123 hasConcept C42219234 @default.
• W4385216123 hasConcept C42407357 @default.
• W4385216123 hasConcept C46973012 @default.
• W4385216123 hasConcept C54355233 @default.
• W4385216123 hasConcept C66322754 @default.
• W4385216123 hasConcept C71924100 @default.
• W4385216123 hasConcept C86803240 @default.
• W4385216123 hasConceptScore W4385216123C105795698 @default.
• W4385216123 hasConceptScore W4385216123C122048520 @default.
• W4385216123 hasConceptScore W4385216123C126322002 @default.
• W4385216123 hasConceptScore W4385216123C126838900 @default.
• W4385216123 hasConceptScore W4385216123C131872663 @default.
• W4385216123 hasConceptScore W4385216123C143753070 @default.
• W4385216123 hasConceptScore W4385216123C170493617 @default.
• W4385216123 hasConceptScore W4385216123C172680121 @default.
• W4385216123 hasConceptScore W4385216123C201614185 @default.
• W4385216123 hasConceptScore W4385216123C2777652975 @default.
• W4385216123 hasConceptScore W4385216123C2778194526 @default.
• W4385216123 hasConceptScore W4385216123C2778376644 @default.
• W4385216123 hasConceptScore W4385216123C2778780700 @default.
• W4385216123 hasConceptScore W4385216123C2779234561 @default.
• W4385216123 hasConceptScore W4385216123C2781063702 @default.
• W4385216123 hasConceptScore W4385216123C33923547 @default.
• W4385216123 hasConceptScore W4385216123C42219234 @default.
• W4385216123 hasConceptScore W4385216123C42407357 @default.
• W4385216123 hasConceptScore W4385216123C46973012 @default.
• W4385216123 hasConceptScore W4385216123C54355233 @default.
• W4385216123 hasConceptScore W4385216123C66322754 @default.
• W4385216123 hasConceptScore W4385216123C71924100 @default.
• W4385216123 hasConceptScore W4385216123C86803240 @default.
• W4385216123 hasIssue "2" @default.
• W4385216123 hasLocation W43852161231 @default.
• W4385216123 hasLocation W43852161232 @default.
• W4385216123 hasOpenAccess W4385216123 @default.

• next